ReLive Biotechnologies LTD
About:
ReLive is spearheading regenerative cell therapies to address unmet needs in the areas of orthopedic sports medicine and plastic surgery.
Website: https://www.relivebio.com
Top Investors: Shanghai Healthcare Capital, Jiuyou Capital, Indaco Capital
Description:
ReLive is a biotechnology company that develops orthopedic sports medicine and plastic and reconstructive surgery projects based on regenerative medicine and cell therapy science.
Total Funding Amount:
$50M
Headquarters Location:
Newton, Massachusetts, United States
Founded Date:
2021-06-01
Founders:
Xing Zhao, Ying Zhou
Number of Employees:
51-100
Last Funding Date:
2023-01-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai